Does Earnings Surprise History Hold Any Clue for Hologic (NASDAQ:HOLX)

Earnings results for Hologic (NASDAQ:HOLX)

Hologic, Inc. is expected* to report earnings on 04/28/2021 after market close. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 8 analysts’ forecasts, the consensus EPS forecast for the quarter is $2.62. The reported EPS for the same quarter last year was $0.57.

Hologic last released its earnings results on January 27th, 2021. The medical equipment provider reported $2.86 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.72. The business earned $1.61 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Its revenue was up 89.3% compared to the same quarter last year. Hologic has generated $3.98 earnings per share over the last year and currently has a price-to-earnings ratio of 17.3. Hologic has confirmed that its next quarterly earnings report will be published on Wednesday, April 28th, 2021.

Analyst Opinion on Hologic (NASDAQ:HOLX)

13 Wall Street analysts have issued ratings and price targets for Hologic in the last 12 months. Their average twelve-month price target is $88.50, predicting that the stock has a possible upside of 21.48%. The high price target for HOLX is $110.00 and the low price target for HOLX is $64.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Hologic has received a consensus rating of Buy. The company’s average rating score is 2.77, and is based on 10 buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $88.50, Hologic has a forecasted upside of 21.5% from its current price of $72.85. Hologic has only been the subject of 4 research reports in the past 90 days.

Dividend Strength: Hologic (NASDAQ:HOLX)

Hologic does not currently pay a dividend. Hologic does not have a long track record of dividend growth.

Insiders buying/selling: Hologic (NASDAQ:HOLX)

In the past three months, Hologic insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $707,867.00 in company stock. Only 1.00% of the stock of Hologic is held by insiders. 92.43% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Hologic (NASDAQ:HOLX

Earnings for Hologic are expected to decrease by -34.59% in the coming year, from $7.17 to $4.69 per share. The P/E ratio of Hologic is 17.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.35. The P/E ratio of Hologic is 17.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 45.73. Hologic has a PEG Ratio of 0.62. PEG Ratios below 1 indicate that a company could be undervalued. Hologic has a P/B Ratio of 6.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here